Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Neurobo Pharmaceuticals (NASDAQ: NRBO ) stock is on the rise Tuesday as retail traders take a liking to the biotechnology company. Source: Bukhta Yurii / Shutterstock.com The recent interest from retail trader...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Robinhood is holding a roadshow this weekend to go over details of the company’s upcoming initial public offering (IPO). Source: mundissima / Shutterstock.com The Robinhood IPO Roadshow is set to take place...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips NeuroMetrix (NASDAQ: NURO ) stock is surging higher on Tuesday after getting “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA). Source: Shutterstock The breakthro...
Gainers: NeuroBo Pharmaceuticals (NRBO) +50%, NeuroMetrix (NURO) +41%, Immunome (IMNM) +31%, Endo International (ENDP) +21%, PLx Pharma (PLXP) +18%.Losers: Ardelyx (ARDX) -75%, Allied Healthcare Products (AHPI) -22%, NRx Pharmaceuticals (...
WOBURN, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell ® device has received Breakthrough Designation from the U.S. Food and Drug Administration (FDA) for treating the symptoms of fibromyalgia in adults. Fibromyalgia i...
WOBURN, Mass., July 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 second quarter financial results before the opening of the market on July 22, 2021. The Company will host a conference call at 8:00 a.m., Eastern Time on July 22...
WOBURN, Mass., June 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology will be used in a double-blinded, randomized, sham-controlled trial to determine whether transcutaneous electrical nerve stimulation (TENS) is an effective, acceptable and...
Clearside Biomedical (CLSD) +52% after positive results from early-stage wet AMD trial.Torchlight Energy Resources (TRCH) +33% after declaring special preferred dividend.Unique Fabricating (UFAB) +29%.Ocugen (OCGN) +20% after securing manufacturing partnership for COVAXIN in th...
NeuroMetrix (NURO) perks up 6.6% premarket after announcing top-line results from Quell trial in patients with fibromyalgia. Quell is a novel transcutaneous electrical nerve stimulator ((TENS)) that is indicated for relief and management of chronic pain. A poster titled "Outcom...
WOBURN, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that top-line results from a randomized controlled trial of Quell in patients with fibromyalgia will be presented at two upcoming pain medicine conferences. The double-blind, randomized, s...
News, Short Squeeze, Breakout and More Instantly...
WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2024. The Company's mission is to reduce the impact of neurological disorders and pain syndromes through innovative non-invasive medica...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...